Stephanie Brown

Stephanie Brown, BSc, MBA, currently serves as a Member of the Board of Directors at Resilia Inc, a company specializing in the Uresta pessary for stress urinary incontinence. Previously, Stephanie held the position of President, North America, and a member of the Executive Management Team at Santhera Pharmaceuticals, overseeing a significant licensing deal and corporate restructuring. Additional board experience includes a role at ObsEva SA, focusing on the Audit Committee. Stephanie has held senior leadership positions in notable pharmaceutical companies, including Ipsen, Novartis, Takeda, Biogen, Genentech, and Merck, primarily in rare diseases, neuroscience, and oncology. Educational credentials include an MBA from Heriot-Watt University, a course on Women on Boards from Harvard T.H. Chan School of Public Health, and a Bachelor of Science in Chemistry with Biology from Mount Allison University.